GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

GemVax&KAEL Revenue

GemVax&KAEL had revenue of 17.98B KRW in the quarter ending September 30, 2025, with 41.16% growth. This brings the company's revenue in the last twelve months to 73.64B, up 17.39% year-over-year. In the year 2024, GemVax&KAEL had annual revenue of 62.69B, down -13.18%.

• Revenue (ttm): 73.64B
• Revenue Growth: +17.39%
• P/S Ratio: 16.54
• Revenue / Employee: 404.62M
• Employees: 182
• Market Cap: 1.22T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	62.69B	-9.52B	-13.18%
Dec 31, 2023	72.21B	-3.60B	-4.74%
Dec 31, 2022	75.80B	15.43B	25.56%
Dec 31, 2021	60.37B	-5.29B	-8.06%
Dec 31, 2020	65.66B	23.00B	53.91%